SciELO - Scientific Electronic Library Online

 
vol.21 issue3ESQUIZO-Q: An Instrument for the Assessment of "Psychometric High Risk" for PsychosisPsychotherapy of Psychosis: From the Subject at Risk to the Chronic Patient author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Clínica y Salud

On-line version ISSN 2174-0550Print version ISSN 1130-5274

Abstract

PEREZ ESCUDERO, Adela; GIL MOLINA, Santiago; PINA CAMACHO, Laura  and  GARCIA-CABEZA, Ignacio. Psychopharmacology of Psychosis: Choice of Drug, Treatment Adherence and New Horizons. Clínica y Salud [online]. 2010, vol.21, n.3, pp.271-283. ISSN 2174-0550.

The authors present an update on the antipsychotic treatment of psychosis, focusing on 3 aspects: choice of antipsychotic drugs, the problem of adherence and treatments still being investigated. The antipsychotic drug chosen in the treatment should take into consideration the individual characteristics of each patient, patients’ preferences and the clinical characteristics of the disease. The principal treatment guidelines in order to make an adequate choice of drug, considering the action mechanism and secondary effects profile, clinical response, disease phase, resistant patients, and so on, are reviewed. One of the most important problems of drug treatment in psychosis is to achieve a good adherence rate. Thus, the psychopharmacological, psychotherapeutical and psychosocial strategies that may favor this are reviewed. Current research focuses on the search for new drugs with atypicity characteristics similar to those that already exist (blockage of multiple receptors, partial dopamine agonism), already known atypical drugs with new presentations, mostly delayed action drugs that may favor adherence, and new targets, especially action on the glutamatergic pathway.

Keywords : psychosis; classic antipsychotics; atypical antipsychotics; adherence.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License